Literature DB >> 10187770

CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10.

T Koseki1, N Inohara, S Chen, R Carrio, J Merino, M O Hottiger, G J Nabel, G Núñez.   

Abstract

We have identified and characterized CIPER, a novel protein containing a caspase recruitment domain (CARD) in its N terminus and a C-terminal region rich in serine and threonine residues. The CARD of CIPER showed striking similarity to E10, a product of the equine herpesvirus-2. CIPER formed homodimers via its CARD and interacted with viral E10 but not with several apoptosis regulators containing CARDs including ARC, RAIDD, RICK, caspase-2, caspase-9, or Apaf-1. Expression of CIPER induced NF-kappaB activation, which was inhibited by dominant-negative NIK and a nonphosphorylable IkappaB-alpha mutant but not by dominant-negative RIP. Mutational analysis revealed that the N-terminal region of CIPER containing the CARD was sufficient and necessary for NF-kappaB-inducing activity. Point mutations in highly conserved residues in the CARD of CIPER disrupted the ability of CIPER to activate NF-kappaB and to form homodimers, indicating that the CARD is essential for NF-kappaB activation and dimerization. We propose that CIPER acts in a NIK-dependent pathway of NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10187770     DOI: 10.1074/jbc.274.15.9955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.

Authors:  J Tadokoro; Y Nakamura; S Furusawa; K Mitani
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.

Authors:  H Ye; A Dogan; L Karran; T G Willis; L Chen; I Wlodarska; M J Dyer; P G Isaacson; M Q Du
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

Authors:  Joel L Pomerantz; Elissa M Denny; David Baltimore
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 5.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 6.  Inhibiting the inflammasome: one domain at a time.

Authors:  Andrea Dorfleutner; Lan Chu; Christian Stehlik
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 7.  Molecular basis of lysophosphatidic acid-induced NF-κB activation.

Authors:  Wenjing Sun; Jianhua Yang
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

8.  Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Authors:  Erika Scharschmidt; Elmar Wegener; Vigo Heissmeyer; Anjana Rao; Daniel Krappmann
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 9.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 10.  Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Authors:  Lara M Kingeter; Brian C Schaefer
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.